MedPath

Maxillary Canine Retraction Assisted With Micro-osteoperforations Versus Injectable Platelet Rich Fibrin

Phase 2
Conditions
Effects of; Movement of Teeth Assiste Wit MOPS and I-prf
Interventions
Combination Product: injectable platelet rich fibrin versus microosteoperforation
Registration Number
NCT05960825
Lead Sponsor
Al-Azhar University
Brief Summary

The present clinical comparative study will be undertaken for assessment of two different modalities of maxillary canine retraction assisted with microosteoperforations versus injectable platelet rich fibrin.

Detailed Description

Group I: will include 9 patients who willreceive MOPs with maxillary canine retraction that will be performed on intervention sides according to a standardized protocol.

▪ Group II: will include 9 patients receive i-PRF that will be performed on intervention sides according to a standardized protocol.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
18
Inclusion Criteria
  1. An age ranges from 15-22 years.
  2. Severe crowding or protrusion requiring 1st premolars extractions followed by symmetrical canine retraction.
  3. All permanent teeth present, 3rd molars are excluded.
  4. Good oral and general health.
  5. No systemic disease/medication that could interfere with OTM.
  6. No previous orthodontic treatment.
Exclusion Criteria
  1. Patient diagnosed to have an indication for non-extraction approach.
  2. Poor oral hygiene or periodontally compromised patient.
  3. Patient with craniofacial anomalies or previous history of trauma, bruxism or parafunctions.
  4. Previous orthodontic treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Group MOPsinjectable platelet rich fibrin versus microosteoperforationGroup MOPs : will include 9 patients who willreceive MOPs with maxillary canine retraction that will be performed on intervention sides according to a standardized protocol.
Group i-PRFinjectable platelet rich fibrin versus microosteoperforationgroup i-PRF: will include 9 patients receive i-PRF that will be performed on intervention sides according to a standardized protocol
Primary Outcome Measures
NameTimeMethod
Direct clinical assessment of the amount of maxillary canine retraction i.e. amount of extraction space closure before and after four months observation period and on every 28 days observation period according to standardized method4months

Direct clinical assessment of the amount of maxillary canine retraction i.e. amount of extraction space closure before and after four months observation and every 28 days period and on every 28 days observation period according to standardized method. 2. Study cast assessment:

• The amount of maxillary canine retraction on both sides will be measured immediately before starting canine retraction and at each observation interval by using a software for the scanned models according to standardized method

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

AlAzhar university

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath